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Cardiomyocytes, the cells of the heart muscle, lose nearly all of their proliferative capacity after
birth, limiting the heart’s ability to regenerate. Naqvi et al. now identify a transient burst of cardio-
myocyte proliferation during preadolescence, driven by a thyroid hormone surge, with therapeutic
implications for congenital and acquired heart diseases.Heart size is tightly regulated across
species (Heallen et al., 2011). Some ver-
tebrates such as fish and amphibians
display robust, life-long capacity to reac-
tivate proliferation of cardiomyocytes
in response to injury, and the ability
to completely regenerate their hearts
without scar formation (Zhang et al.,
2013). In mammals, however, cardiomyo-
cytes undergo cell-cycle withdrawal soon
after birth, and the majority of postnatal
cardiac growth has been attributed to
cardiomyocytes growing in size, with little
proliferation (Bergmann et al., 2009). In
line with this observation, recent mouse
studies revealed that mammals possess
the capacity for complete cardiac regen-
eration immediately after birth (postnatal
day 2 [P2]) but lose this ability precipi-
tously by P7 (Porrello et al., 2011). Now,
in this issue of Cell, Ahmad Husain and
colleagues (Naqvi et al., 2014) identify a
new window of transient cardiomyocyte
proliferation in preadolescent (P15)
mouse hearts, which appears to be regu-
lated through pathways known to modu-
late the early postnatal stages of heart
development.
Using a combination of careful histo-
morphometry and dispersed cell counts,
Naqvi et al. showed that cardiomyocyte
size alone cannot account for the change
in heart weight observed in the postnatal
mouse heart (P10–P35), suggesting that
an increase in cardiomyocyte number
must also occur during this period. In
support of this idea, they identified two
time windows during which cardiomyo-cyte population number increased: the
first occurs during P1–P4 with a 40%
increase in cardiomyocyte number, and
the second occurs between P14–P18
with a second 40% increase in cardio-
myocyte cell number (Figure 1). Following
the second burst and up to a year later,
cardiomyocyte numbers remained the
same. These findings set the stage for
an exquisite line of experiments, showing
that cardiomyocyte proliferation in the
preadolescent heart occurs during a
very tight time window. The authors found
that the expression of cell-cycle genes is
5- to 12-fold higher by 9 a.m. on P15, re-
verting to previous levels by P16. Pulse-
chase experiments, measuring BrdU
incorporation into S phase nuclei, also
showed that cardiomyocytes start under-
going mitosis during the night of P14.
Furthermore, transverse heart sections
stained for aurora B, a kinase only
expressed in M phase, revealed a 36-
fold increase in cells undergoing mitosis
between P14–P15, which dropped 5.8-
fold by P16. Interestingly, and in contrast
to the early postnatal heart (P2) which
shows ubiquitous proliferation of cardio-
myocytes, Naqvi et al. provided evidence
for an unequal distribution of proliferating
cardiomyocytes throughout the preado-
lescent heart. The vast majority of
proliferation appeared to occur within
the subendocardial (inner) zone of the
left ventricle, with little proliferation in
the subepicardial (outer) region of the
left ventricle, the right ventricle, or atria.
These findings are provocative becauseCelthey suggest a more complex level of
regulation, acting to specify a unique
domain of cardiomyocyte responsive-
ness to proliferation signals. This re-
gionalization of proliferation could be
exploited in future studies to identify
mechanisms regulating cardiomyocyte
proliferation in the postmitotic heart
based on common molecular/phenotypic
signatures between the P2 heart and P15
subendocardium.
While investigating the mechanism
leading to preadolescent cardiomyocyte
mitosis, Naqvi et al. made a surprising
finding pertaining to the challenge of
initiating division in multinucleated cells
such as cardiomyocytes. Mouse cardio-
myocytes that undergo cell-cycle with-
drawal typically experience a final round
of DNA synthesis and nuclear division
without cytokinesis, leading to bi- or
multinucleation (Laflamme and Murry,
2011). Naqvi et al. found a 2.3-fold
increase in mononucleated cells in the
afternoon of P15, coupled with a 60%
decrease in binucleated cells, suggest-
ing that binucleated cells give rise to
mononucleated cells. They proposed a
model according to which binuclear cells
undergo karyokinesis of the two nuclei
with cytokinesis taking place between
the pair of nuclei. The end result of
such division would be two mononuclear
cells at the two poles and a smaller
binucleated cardiomyocyte generated
between them. Previous studies have
shown that such 2+1 mitosis is feasible
(Engel et al., 2005), providing anl 157, May 8, 2014 ª2014 Elsevier Inc. 765
Figure 1. Cardiomyocyte Proliferation and Regenerative Potential during Heart Development
The transition during heart development from proliferation to terminal differentiation has just gottenmore complex. In the early postnatal period (P2mouse panel),
cardiomyocytes robustly proliferate and heart muscle has the ability to fully recover from injury. This regenerative capacity is lost by postnatal day 7 and is not
retained in adulthood (P21mouse panel). Naqvi et al. now show that cardiomyocyte proliferation is reactivated during a narrow time window in the preadolescent
mouse heart (P15 mouse panel), delineating the cellular and molecular processes underlying this process. These findings provide new insights into the complex
relationship between proliferation and regeneration in the postnatal heart.interesting starting point to study mech-
anisms of activating cell proliferation
in the multinucleated postmitotic adult
heart.
Postnatal bursts in serum factors such
as the thyroid hormone tri-iodothyronine
(T3) and insulin-like growth factor 1
(IGF1) are responsible for some of the
key structural and functional changes of
the postnatal heart (Forhead and Fowden,
2014). Based on this, Naqvi et al.
measured serum T3 levels during the pre-
adolescent stage and found a 5.6-fold
increase between P10–P12. Propyl-
thiouracil (PTU) treatment, which inhibits
T3 biosynthesis, blocked the cardiac
growth observed during the P14–P15
period. The lag between the T3 spike
and the proliferative burst suggests an
indirect mechanism, and in support of
this notion, the authors suggested that
T3 acts directly on the IGF1 signaling
pathway to mediate these events. This is
supported by the observation that Akt, a
downstream component of IGF signaling,766 Cell 157, May 8, 2014 ª2014 Elsevier Incis found in nuclei only within the subendo-
cardial region of the left ventricle on P15
and that PTU treatment abrogated IGF1-
R/Akt pathway activity in P15 ventricles.
Curiously, previous studies in late-term
fetal sheep have indicated that T3 causes
cardiomyocyte cell-cycle withdrawal
(Chattergoon et al., 2012) and work from
our laboratory has used T3 treatment as
a modality for maturing hESC-derived
cardiomyocytes with similar effects
observed in the downregulation of cell
proliferation (Yang et al., 2014). There is
a clear discrepancy between these find-
ings, suggesting a context-dependent
effect of T3 in modulating cardiomyocyte
proliferation versus maturation, poten-
tially through an IGF1R/Akt dependent
process.
Lastly, Naqvi et al. tested the hypothe-
sis that a transient window of cardiomyo-
cyte proliferation may confer protec-
tion against acute myocardial injury
by comparing response to myocardial
infarction at different ages: in P2, P15,.and P21 mice. Consistent with previous
studies, Naqvi et al. observed that the
P2 heart is capable of scarless cardiac
regeneration postmyocardial infarction,
correlating to increased cell-cycle activity
in those hearts. In contrast, the P21
heart, which has no detectible cardio-
myocyte cell-cycle activity, shows
massive scarring and no regeneration.
Based on a localized state of cardiomyo-
cyte proliferation postinfarction, Naqvi
et al. showed an intermediate potential
for cardiac regeneration in the P15 heart.
While this experiment provided some
evidence for the protective effect of
cardiomyocyte proliferation, testing the
regenerative ability of a heart before the
preadolescent burst (e.g., at P7), and
showing that at P15 the heart can regen-
erate better than at P7, would have been
more persuasive.
In summary, to our knowledge this
study provides the first evidence that
mature multinucleated cardiomyocytes
can re-enter the cell cycle and
significantly contribute to cardiomyocyte
proliferation. The mechanism and causal
relationship between T3/IGF signaling
and this proliferative burst remain unclear,
and further studies will be needed to more
specifically address these issues. Addi-
tional fate mapping studies that condi-
tionally label postmitotic cardiomyocytes
would help elucidate this phenomenon
and determine themolecular mechanisms
responsible for mediating this effect.
Indeed, this study takes a step forward
in identifying ways to stimulate prolifera-
tion in postmitotic cardiomyocytes and
may yield valuable insights into therapeu-
tic treatments for inherited and acquired
heart diseases.REFERENCES
Bergmann, O., Bhardwaj, R.D., Bernard, S.,
Zdunek, S., Barnabe´-Heider, F., Walsh, S.,
Zupicich, J., Alkass, K., Buchholz, B.A., Druid, H.,
et al. (2009). Science 324, 98–102.
Chattergoon, N.N., Giraud, G.D., Louey, S., Stork,
P., Fowden, A.L., and Thornburg, K.L. (2012).
FASEB J. 26, 397–408.
Engel, F.B., Schebesta, M., Duong, M.T., Lu, G.,
Ren, S., Madwed, J.B., Jiang, H., Wang, Y., and
Keating, M.T. (2005). Genes Dev. 19, 1175–1187.
Forhead, A.J., and Fowden, A.L. (2014).
J. Endocrinol. Published online March 19, 2014.
http://dx.doi.org/10.1530/JOE-14-0025.
Heallen, T., Zhang, M., Wang, J., Bonilla-Claudio,
M., Klysik, E., Johnson, R.L., and Martin, J.F.
(2011). Science 332, 458–461.CelLaflamme, M.A., and Murry, C.E. (2011). Nature
473, 326–335.
Naqvi, N., Li, M., Calvert, J.W., Tejada, T., Lambert,
J.P., et al. (2014). Cell 157, this issue, 795–807.
Porrello, E.R., Mahmoud, A.I., Simpson, E., Hill,
J.A., Richardson, J.A., Olson, E.N., and Sadek,
H.A. (2011). Science 331, 1078–1080.
Yang, X., Rodriguez, M., Pabon, L., Fischer, K.A.,
Reinecke, H., Regnier, M., Sniadecki, N.J., Ruo-
hola-Baker, H., and Murry, C.E. (2014). J. Mol.
Cell. Cardiol. Published online April 13, 2014.
http://dx.doi.org/10.1016/j.yjmcc.2014.04.005.
Zhang, R., Han, P., Yang, H., Ouyang, K., Lee, D.,
Lin, Y.F., Ocorr, K., Kang, G., Chen, J., Stainier,
D.Y., et al. (2013). Nature 498, 497–501.Deciphering Functions
of Branched Ubiquitin Chains
Jaime Lo´pez-Mosqueda1 and Ivan Dikic1,*
1Institute of Biochemistry II, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany
*Correspondence: dikic@biochem2.uni-frankfurt.de
http://dx.doi.org/10.1016/j.cell.2014.04.026
The anaphase-promoting complex/cyclosome targets proteins for degradation by catalyzing ho-
motypic ubiquitin chains of different linkage types. In this issue of Cell, Meyer and Rape diversify
the degradation signals by demonstrating that the APC/C and its cognate E2 conjugating enzymes
enhance the rate of substrate degradation by decorating them with branched Lys11 and Lys48
ubiquitin chains.Ubiquitylation is the most versatile post-
translational modification known to date
and is involved in the regulation of
numerous cellular processes (Grabbe
et al., 2011). Ubiquitin (Ub) is predomi-
nantly attached to lysine residues of
other proteins by a tightly regulated
multistep enzymatic process involving
activation by E1 enzymes, conjugation
by E2 enzymes, and, finally, ligation by
E3 ligases. Attachment of Ub may result
in monoubiquitylated proteins or modifi-
cation with Ub chains composed of
several Ub moieties. In the latter case,
the internal seven lysines or the amino-
terminal methionine 1 of Ub are modifiedin successive rounds of conjugation.
Given these multiple linkage sites, the
pool of theoretically viable Ub chains
with different structures is almost unlim-
ited, underscoring the versatility of the
system. However, so far, only a limited
number of defined Ub structures were
identified in vivo, and research has
mainly concentrated on chains of
homogenously linked Ub. In this issue
of Cell, Meyer and Rape (2014) define a
physiological role for branched Ub chains
in cell-cycle regulation. This may mark
the entry into a new era of Ub research
and definitely adds a new twist to the
deciphering of the Ub code, as well asto the understanding of the enzymatic
machinery involved.
In eukaryotes, destruction of cell-
cycle regulators is essential for progres-
sion through and exit out of mitosis.
The anaphase-promoting complex/cy-
closome (APC/C) is a large, multisubunit
E3 ligase that targets key cell-cycle reg-
ulators for ubiquitylation and subsequent
degradation by the 26S proteasome
(Peters, 2006). The first Ub chains
described to relate such signals were
Lys48 linked Ub chains, but how the
APC/C functioned to catalyze these
chain types remained unknown. Mecha-
nistic details emerged from studies inl 157, May 8, 2014 ª2014 Elsevier Inc. 767
